How much funding has Prime Medicine raised?

Prime Medicine has raised $339.0M in total funding, most recently a Grant round.

Who are Prime Medicine's investors?

Prime Medicine's investors include Newpath Management, Cystic Fibrosis Foundation, ARCH Venture Partners, F-Prime Capital, GV, Casdin Capital.

When was Prime Medicine founded?

Prime Medicine was founded in 2019.

Where is Prime Medicine headquartered?

Prime Medicine is headquartered in Cambridge, Massachusetts, United States.

What industry is Prime Medicine in?

Prime Medicine operates in Biotech, Healthcare.

How many employees does Prime Medicine have?

Prime Medicine has 201-500 employees.

Prime Medicine

IPO

Delivering on the promise of Prime Editing

Public · Cambridge, United States · Founded 2019 · $339.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 201–500
Founded: 2019
Business Model: B2B
Website: primemedicine.com

Total Funding: $339.0M
Last Round: $24.0M GrantJul 2025
Rounds: 3
Type: Public

About

Prime Medicine develops next-generation gene therapies using its proprietary Prime Editing platform, which can search and replace disease-causing genetic sequences without causing double-strand DNA breaks. Founded in 2019 based on technology from the Broad Institute, the company focuses on liver, lung, immunology, and oncology indications. It has a strategic collaboration with Bristol Myers Squibb and is advancing programs toward IND filings.

Summary

Prime Medicine is a Biotech company based in Cambridge, United States, founded in 2019. It has raised $339.0M in total across 3 rounds, most recently a $24.0M Grant round in Jul 2025. Investors include Newpath Management, Cystic Fibrosis Foundation and ARCH Venture Partners.

LinkedIn X (Twitter)